Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers

This article was originally published in The Tan Sheet

Executive Summary

FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children
Advertisement

Related Content

Regulatory News In Brief
Regulatory News In Brief
NRDC wants FDA to act on BPA
NRDC wants FDA to act on BPA
NRDC wants FDA to act on BPA
Formula makers shift away from BPA
Formula makers shift away from BPA
Formula makers shift away from BPA
Dingell, Stupak ask firms to remove BPA

Topics

Advertisement
UsernamePublicRestriction

Register

PS103720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel